To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NRMTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
226 supporting clones for gene NRM back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA000315   .l-u 2 to 492 2 to 492 M52T capped   491/491
(100 %)
1 diff
(99.8 %id)
AF143676   .a 356 to 1754 1 to 1400       1400/1403
(99 %)
2 diff
(99.9 %id)
AK075509 whole embryo, mainly head .a 1 to 1753 2 to 1754 S14P tiling clone,   1754/1754
(100 %)
3 diff
(99.9 %id)
AK298152   .f 1 to 1213 3 to 1215 exact tiling clone,   1215/1215
(100 %)
4 diff
(99.7 %id)
AK315190 placenta .a 344 to 1142 1 to 799       799/799
(100 %)
0 diff
(100 %id)
DA029305   .l-u 1 to 558 2 to 560 R47L E48G S50I R51E M52D ... tiling clone, capped   559/559
(100 %)
2 diff
(99.7 %id)
AW577340 breast .h-u 1 to 598 595 to 1 L30P L56R tiling clone,   595/596
(99 %)
12 diff
(98.0 %id)
AW799736 uterus .h-u 237 to 733 498 to 3       496/518
(95 %)
0 diff
(100 %id)
AW976659   .h-u 415 to 998 585 to 1     Submitted on the opposite strand 585/589
(99 %)
3 diff
(99.5 %id)
AY358411   .a 335 to 1752 1 to 1418       1418/1425
(99 %)
1 diff
(100.0 %id)
BC039865 Testis, embryonal carcinoma .a 336 to 1753 1 to 1418   tiling clone, available from MGC, AAA   1418/1418
(100 %)
0 diff
(100 %id)
BF839747 head_neck .h-u 360 to 836 477 to 1     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
BG945369 amnion_normal .h-u 115 to 596 1 to 481 E5V P6S L7G A8P L9E ...     481/481
(100 %)
5 diff
(99.0 %id)
BI024034 marrow .h-u 721 to 950 1 to 231       231/231
(100 %)
14 diff
(94.0 %id)
BI024538 marrow .a 770 to 1113 1 to 344       344/344
(100 %)
4 diff
(98.9 %id)
DA067983 cerebellum .l-u 2 to 557 2 to 557 exact capped   556/556
(100 %)
2 diff
(99.7 %id)
CD049763 embryonic stem cells, WA01, passage 38 .a 451 to 1310 19 to 882       864/886
(97 %)
16 diff
(98.2 %id)
CN358959 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 365 to 838 1 to 473       473/473
(100 %)
3 diff
(99.4 %id)
CN358960 embryonic stem cells, cell lines H1, H7, andH9 .a 342 to 736 1 to 395       395/395
(100 %)
6 diff
(98.5 %id)
CN358961 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 369 to 921 1 to 553       553/553
(100 %)
3 diff
(99.5 %id)
CN358962 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h-u 112 to 584 1 to 473 exact     473/473
(100 %)
0 diff
(100 %id)
CN358963 embryonic stem cells, DMSO-treated H9 cellline .a 754 to 1503 1 to 750       750/750
(100 %)
1 diff
(99.9 %id)
CN358964 embryonic stem cells, DMSO-treated H9 cellline .h-u 500 to 995 1 to 496       496/496
(100 %)
6 diff
(98.8 %id)
CR592223 Placenta Cot 25-normalized .a 362 to 1738 1 to 1377       1377/1377
(100 %)
2 diff
(99.9 %id)
CR596567 Neuroblastoma Cot 25-normalized .e 44 to 1433 1 to 1390 exact tiling clone,   1390/1390
(100 %)
2 diff
(99.9 %id)
CR597197 Placenta Cot 25-normalized .a 341 to 1743 1 to 1403       1403/1403
(100 %)
2 diff
(99.9 %id)
CR604044 B cells (Ramos cell line) Cot 25-normalized .a 346 to 1723 1 to 1378       1378/1378
(100 %)
2 diff
(99.9 %id)
CR604619 neuroblastoma .e 20 to 1421 1 to 1402 exact     1402/1402
(100 %)
2 diff
(99.9 %id)
CR606826 Neuroblastoma Cot 25-normalized .h-u 202 to 1000 1 to 799       799/799
(100 %)
1 diff
(99.9 %id)
CR608026 HeLa cells Cot 25-normalized .a 345 to 1750 1 to 1406       1406/1406
(100 %)
2 diff
(99.9 %id)
CR609683 Neuroblastoma Cot 25-normalized .f 18 to 1186 1 to 1169 exact tiling clone,   1169/1169
(100 %)
2 diff
(99.9 %id)
CR614897 Neuroblastoma Cot 10-normalized .a 364 to 1716 1 to 1353       1353/1353
(100 %)
2 diff
(99.9 %id)
CR616786 T cells (Jurkat cell line) Cot10-normalized .h-u 510 to 1000 1 to 491       491/491
(100 %)
0 diff
(100 %id)
CR618359 Neuroblastoma Cot 10-normalized .e 44 to 1417 1 to 1374 exact     1374/1374
(100 %)
2 diff
(99.9 %id)
CR619257 neuroblastoma .a 462 to 1726 1 to 1265       1265/1265
(100 %)
2 diff
(99.9 %id)
CR623441 Neuroblastoma Cot 10-normalized .a 374 to 1725 1 to 1352       1352/1352
(100 %)
2 diff
(99.9 %id)
AL516523 brain, neuroblastoma, neuroblastoma cells .a 687 to 1725 1031 to 1       1031/1031
(100 %)
19 diff
(98.2 %id)
AL516524 brain, neuroblastoma, neuroblastoma cells .e 20 to 1083 1 to 1054 A168X     1054/1062
(99 %)
21 diff
(98.1 %id)
BX445517 neuroblastoma .e 20 to 929 1 to 909 W2X P25H P39X P45X A69S ...     909/909
(100 %)
22 diff
(97.6 %id)
BX438526 neuroblastoma .a 687 to 1721 1036 to 1       1036/1036
(100 %)
56 diff
(94.6 %id)
BX447254 neuroblastoma .a 750 to 1726 976 to 1       976/976
(100 %)
9 diff
(99.1 %id)
BX447255 neuroblastoma .a 462 to 1379 1 to 917       917/917
(100 %)
1 diff
(99.9 %id)
AL521046 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1009 to 1724 715 to 1   fully sequenced,   715/715
(100 %)
7 diff
(99.1 %id)
AL521047 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 374 to 1039 1 to 652   fully sequenced,   652/652
(100 %)
1 diff
(99.9 %id)
AL520377 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1018 to 1716 699 to 1   fully sequenced,   699/699
(100 %)
7 diff
(99.0 %id)
AL520378 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 364 to 1048 1 to 672   fully sequenced,   672/672
(100 %)
3 diff
(99.6 %id)
AL522626 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 838 to 1401 579 to 16   fully sequenced,   564/579
(97 %)
0 diff
(100 %id)
AL522627 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 44 to 868 1 to 824 W2X D67X L74X R103X fully sequenced,   824/824
(100 %)
1 diff
(99.9 %id)
AL523530 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 44 to 1117 1 to 1059 exact     1059/1090
(97 %)
19 diff
(98.3 %id)
BX329563 Neuroblastoma Cot 25-normalized .h-u 776 to 1001 229 to 1   fully sequenced,   229/229
(100 %)
9 diff
(96.1 %id)
BX353660 Neuroblastoma Cot 25-normalized .h-u 579 to 1002 1 to 424   tiling clone, fully sequenced,   424/424
(100 %)
2 diff
(99.6 %id)
BX354079 Neuroblastoma Cot 25-normalized .h-u 247 to 990 743 to 1   fully sequenced,   743/743
(100 %)
9 diff
(98.8 %id)
BX354080 Neuroblastoma Cot 25-normalized .h-u 202 to 1000 1 to 799   tiling clone, fully sequenced,   799/799
(100 %)
1 diff
(99.9 %id)
BX354049 Neuroblastoma Cot 25-normalized .h-u 459 to 947 503 to 16   fully sequenced,   488/503
(97 %)
0 diff
(100 %id)
BX354050 Neuroblastoma Cot 25-normalized .h-u 459 to 998 1 to 540   fully sequenced,   540/540
(100 %)
0 diff
(100 %id)
BX375665 Neuroblastoma Cot 25-normalized .f 713 to 1186 473 to 1   fully sequenced,   473/473
(100 %)
1 diff
(99.8 %id)
BX375666 Neuroblastoma Cot 25-normalized .f 18 to 743 1 to 726 D126X H139X fully sequenced,   726/726
(100 %)
1 diff
(99.9 %id)
BX356707 Placenta Cot 25-normalized .a 1183 to 1743 561 to 1   fully sequenced,   561/561
(100 %)
14 diff
(97.6 %id)
BX356708 Placenta Cot 25-normalized .a 341 to 1213 1 to 858 G49D W50G L51W A52L A53P ... fully sequenced,   858/858
(100 %)
1 diff
(99.9 %id)
BX330547 Placenta Cot 25-normalized .h-u 138 to 994 861 to 1       861/861
(100 %)
14 diff
(98.4 %id)
BX381388 Placenta Cot 25-normalized .h-u 122 to 962 842 to 1 exact     842/842
(100 %)
2 diff
(99.8 %id)
BX340391 Placenta Cot 25-normalized .a 362 to 955 1 to 585   fully sequenced,   585/585
(100 %)
2 diff
(99.7 %id)
BX399925 Placenta Cot 25-normalized .a 925 to 1738 816 to 1   fully sequenced,   816/816
(100 %)
18 diff
(97.8 %id)
BX362393   .h-u 510 to 1000 1 to 492       492/492
(100 %)
2 diff
(99.6 %id)
BX352533   .a 1213 to 1750 540 to 1   fully sequenced,   540/540
(100 %)
8 diff
(98.6 %id)
BX401249   .a 345 to 1243 1 to 886 G49D W50G L51W A52L A53P ... fully sequenced,   886/886
(100 %)
3 diff
(99.7 %id)
BX342976   .a 1231 to 1722 491 to 1   fully sequenced,   491/491
(100 %)
6 diff
(98.8 %id)
BX342977   .a 346 to 1261 1 to 916 G49D W50G L51W A52L A53P ... fully sequenced,   916/916
(100 %)
7 diff
(99.3 %id)
EL734353 mixed .a 354 to 1023 1 to 670       670/676
(99 %)
1 diff
(99.9 %id)
DC352226 brain .e 18 to 537 1 to 521       521/521
(100 %)
2 diff
(99.7 %id)
D60301 brain .h-u 643 to 999 356 to 1       356/356
(100 %)
2 diff
(99.5 %id)
D80689 brain .h-u 309 to 596 1 to 284       284/284
(100 %)
17 diff
(94.1 %id)
D81048 brain .h-u 651 to 999 350 to 1   fully sequenced,   350/350
(100 %)
2 diff
(99.5 %id)
D81049 brain .h-u 308 to 681 1 to 373   fully sequenced,   373/373
(100 %)
5 diff
(98.7 %id)
D81509 brain .h-u 308 to 635 1 to 327       327/327
(100 %)
1 diff
(99.7 %id)
BY800370 eye .a 368 to 939 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DA569524 whole embryo, mainly head .a 1 to 454 2 to 455   capped   454/454
(100 %)
3 diff
(99.4 %id)
DB356168 whole embryo, mainly head .a 1193 to 1753 561 to 1       561/561
(100 %)
4 diff
(99.3 %id)
N62823 multiple sclerosis lesions .h-u 703 to 1000 300 to 1   fully sequenced,   300/300
(100 %)
9 diff
(97.0 %id)
W01358 multiple sclerosis lesions .h-u 370 to 733 1 to 361   fully sequenced,   361/361
(100 %)
1 diff
(99.8 %id)
AA126037   .a 1303 to 1554 252 to 1       252/252
(100 %)
0 diff
(100 %id)
AA126176   .a 342 to 766 1 to 409       409/409
(100 %)
19 diff
(95.4 %id)
AA223493 brain, neuroepithelial cells .e 1260 to 1448 195 to 8   tiling clone,   188/195
(96 %)
0 diff
(100 %id)
AA223646 brain, neuroepithelial cells .e 10 to 205 1 to 196       196/196
(100 %)
7 diff
(96.5 %id)
AA455168 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1456 to 1756 305 to 5   tiling clone,   301/305
(98 %)
0 diff
(100 %id)
AA456543 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 369 to 746 1 to 377       377/377
(100 %)
3 diff
(99.3 %id)
AA532557 normal prostatic epithelial cells, Prostate .h-u 325 to 712 9 to 396       388/477
(81 %)
11 diff
(97.7 %id)
AA618528 normal prostate, Prostate .h-u 678 to 999 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AA641339 epithelium (cell line), Prostate .h-u 644 to 769 125 to 1       125/125
(100 %)
1 diff
(99.2 %id)
AA653068 normal prostate, Prostate .h-u 715 to 999 283 to 1       283/283
(100 %)
4 diff
(98.6 %id)
AA742377 germinal center B cell .h-u 510 to 800 291 to 1       291/291
(100 %)
0 diff
(100 %id)
AA742378 germinal center B cell .h-u 618 to 800 183 to 1       183/183
(100 %)
0 diff
(100 %id)
AA809741 germinal center B cell .h-u 885 to 999 126 to 12   AAA   115/115
(100 %)
0 diff
(100 %id)
AA953890 pooled .h-u 688 to 999 312 to 1       312/373
(83 %)
1 diff
(99.8 %id)
AI001879   .h-u 604 to 1001 406 to 11   AAA   396/396
(100 %)
2 diff
(99.5 %id)
AI221185 pooled .h-u 601 to 997 415 to 19   AAA   397/397
(100 %)
1 diff
(99.8 %id)
AI422732 brain, glioblastoma (pooled) .h-u 775 to 997 223 to 1       223/223
(100 %)
1 diff
(99.6 %id)
AI394700 B-cell, chronic lymphotic leukemia .h-u 671 to 998 329 to 2       328/329
(99 %)
0 diff
(100 %id)
AI521967 Kidney .h-u 574 to 1001 441 to 14   AAA   428/428
(100 %)
0 diff
(100 %id)
AI623541 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h-u 604 to 800 197 to 1       197/197
(100 %)
0 diff
(100 %id)
AI654902 pooled germ cell tumors .h-u 669 to 1001 344 to 12   AAA   333/333
(100 %)
0 diff
(100 %id)
AI720030 colon .h-u 659 to 999 341 to 1       341/341
(100 %)
3 diff
(99.2 %id)
AI948526 anaplastic oligodendroglioma, brain .h-u 658 to 1001 361 to 18   AAA   344/344
(100 %)
3 diff
(99.2 %id)
AI971592 pooled germ cell tumors .h-u 660 to 1001 354 to 12   AAA   343/343
(100 %)
5 diff
(98.6 %id)
AW050660 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h-u 874 to 999 126 to 1       126/126
(100 %)
0 diff
(100 %id)
AW296724   .h-u 601 to 997 414 to 18   AAA   397/397
(100 %)
0 diff
(100 %id)
AW276188 lung, two pooled squamous cell carcinomas .h-u 599 to 800 202 to 1       202/202
(100 %)
0 diff
(100 %id)
BE250355 muscle, rhabdomyosarcoma .a 1033 to 1703 683 to 1   fully sequenced,   683/683
(100 %)
21 diff
(97.0 %id)
BE250532 muscle, rhabdomyosarcoma .a 375 to 1063 23 to 706   fully sequenced,   684/706
(96 %)
11 diff
(98.5 %id)
BE299300 muscle, rhabdomyosarcoma .a 366 to 1100 14 to 752       739/854
(86 %)
24 diff
(97.2 %id)
BF515616   .b 221 to 533 18 to 330     Submitted on the opposite strand 313/313
(100 %)
0 diff
(100 %id)
BE328757 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .h-u 645 to 800 156 to 1       156/156
(100 %)
2 diff
(98.8 %id)
BE261392 brain, neuroblastoma .a 355 to 872 1 to 517       517/517
(100 %)
1 diff
(99.9 %id)
BF475368 Prostate .h-u 760 to 999 240 to 1       240/240
(100 %)
1 diff
(99.6 %id)
BE257240 eye, retinoblastoma .a 360 to 1024 1 to 658       658/671
(98 %)
14 diff
(98.0 %id)
BE251256 eye, retinoblastoma .a 396 to 842 1 to 447       447/450
(99 %)
1 diff
(99.8 %id)
BE548635 cervical carcinoma cell line, cervix .b 1 to 602 1 to 601   tiling clone,   601/601
(100 %)
6 diff
(99.1 %id)
BE312340 brain, neuroblastoma .a 398 to 976 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
BE314446 brain, neuroblastoma .a 374 to 952 13 to 594       582/594
(97 %)
10 diff
(98.4 %id)
BE294875 muscle, rhabdomyosarcoma .a 385 to 942 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BE297500 muscle, rhabdomyosarcoma .a 373 to 867 27 to 521       495/522
(94 %)
6 diff
(98.9 %id)
BE266756 lung, small cell carcinoma .k 29 to 717 1 to 700       700/755
(92 %)
28 diff
(96.3 %id)
BE388023 endometrium, adenocarcinoma cell line, uterus .a 1120 to 1756 680 to 18     Submitted on the opposite strand 663/704
(94 %)
0 diff
(100 %id)
BE744361 adenocarcinoma cell line, ovary .d 102 to 865 1 to 751   tiling clone,   751/952
(78 %)
19 diff
(98.1 %id)
BE744966 adenocarcinoma cell line, ovary .d 104 to 851 1 to 742   tiling clone,   742/743
(99 %)
11 diff
(98.6 %id)
BF033935 adenocarcinoma, ovary .d 28 to 839 1 to 800       800/864
(92 %)
53 diff
(93.9 %id)
BF037537 adenocarcinoma, ovary .h-u 146 to 825 1 to 677       677/1000
(67 %)
19 diff
(98.1 %id)
BE782304 eye, retinoblastoma .a 431 to 1099 38 to 697       660/726
(90 %)
15 diff
(98.0 %id)
BE783998 eye, retinoblastoma .a 407 to 976 1 to 577       577/577
(100 %)
9 diff
(98.5 %id)
BE909807 epithelioid carcinoma, Pancreas .d 54 to 704 1 to 651       651/651
(100 %)
3 diff
(99.6 %id)
BE887611 leiomyosarcoma, uterus .g 160 to 914 1 to 759 Q31A V32G Y33I Y34L H35P ... tiling clone,   759/862
(88 %)
22 diff
(97.5 %id)
BC004509 Ovary, adenocarcinoma .a 730 to 1753 1 to 1024   available from MGC, AAA   1024/1024
(100 %)
0 diff
(100 %id)
BE747714 adenocarcinoma cell line, ovary .a 730 to 1536 29 to 833   available from MGC,   805/947
(85 %)
17 diff
(98.3 %id)
BE792687 lung, small cell carcinoma .a 443 to 823 1 to 403       377/406
(92 %)
14 diff
(96.6 %id)
BE797074 lung, small cell carcinoma .a 444 to 1248 1 to 809       807/846
(95 %)
23 diff
(97.3 %id)
BE793743 lung, small cell carcinoma .k 57 to 843 1 to 778   tiling clone,   778/838
(92 %)
18 diff
(97.9 %id)
BE740203 adenocarcinoma cell line, ovary .a 380 to 1072 1 to 689       689/918
(75 %)
11 diff
(98.9 %id)
BF203284 muscle, rhabdomyosarcoma .a 391 to 1074 1 to 673       673/912
(73 %)
13 diff
(98.6 %id)
BF207298 brain, neuroblastoma .h-u 350 to 995 1 to 652       652/849
(76 %)
18 diff
(97.9 %id)
BF304705 muscle, rhabdomyosarcoma .a 365 to 1077 1 to 699       699/921
(75 %)
30 diff
(96.8 %id)
BF312308 brain, neuroblastoma .a 376 to 1040 1 to 658       658/945
(69 %)
18 diff
(98.1 %id)
BF314768 brain, neuroblastoma .a 376 to 1172 1 to 781       781/938
(83 %)
20 diff
(97.9 %id)
BC021260 Brain, neuroblastoma .a 364 to 1751 1 to 1388   available from MGC, AAA   1388/1388
(100 %)
0 diff
(100 %id)
BF317471 brain, neuroblastoma .a 364 to 1083 65 to 775   available from MGC,   711/1023
(69 %)
34 diff
(96.7 %id)
BF316892 brain, neuroblastoma .a 377 to 1040 1 to 656       656/775
(84 %)
20 diff
(97.5 %id)
BF305588 muscle, rhabdomyosarcoma .a 360 to 1085 1 to 717       717/764
(93 %)
27 diff
(96.5 %id)
BF664470 B-cells, primary B-cells from tonsils (cell line) .h-u 466 to 999 24 to 559   AAA   536/559
(95 %)
6 diff
(99.0 %id)
BG119882 adenocarcinoma, cell line, Liver .a 345 to 872 1 to 534       534/535
(99 %)
19 diff
(96.5 %id)
BG256226 adenocarcinoma, cell line, Prostate .f 39 to 694 1 to 653 exact     653/963
(67 %)
8 diff
(99.2 %id)
BG259043 embryonal carcinoma, cell line, testis .d 12 to 774 1 to 762       762/870
(87 %)
14 diff
(98.4 %id)
BG393577 embryonal carcinoma, cell line, testis .a 430 to 1223 1 to 782       782/966
(80 %)
25 diff
(97.5 %id)
BG248395 adenocarcinoma cell line, colon .a 584 to 1166 239 to 834       591/1150
(51 %)
50 diff
(95.7 %id)
BG327426 Kidney, renal cell adenocarcinoma .a 355 to 983 1 to 656       584/917
(63 %)
34 diff
(96.3 %id)
BG421947 Kidney, renal cell adenocarcinoma .a 357 to 1000 1 to 641       641/641
(100 %)
4 diff
(99.4 %id)
BG481162 choriocarcinoma, placenta .b 253 to 1139 1 to 890   tiling clone,   890/921
(96 %)
20 diff
(97.9 %id)
BG503112 embryonal carcinoma, testis .k 34 to 735 1 to 699       699/704
(99 %)
10 diff
(98.6 %id)
BG533801 Liver .j 1 to 817 1 to 824 G21V V22S E23G F24V V25R ... tiling clone,   824/829
(99 %)
57 diff
(93.2 %id)
BG721671 testis .a 196 to 947 1 to 752       750/753
(99 %)
24 diff
(96.9 %id)
BG744013 blood, natural killer cells, cell line .h-u 207 to 996 1 to 793   fully sequenced,   793/793
(100 %)
5 diff
(99.4 %id)
BG744673 blood, natural killer cells, cell line .h-u 208 to 945 736 to 6   fully sequenced,   731/736
(99 %)
0 diff
(100 %id)
BG747504 adenocarcinoma cell line, colon .a 369 to 1066 1 to 756       663/869
(76 %)
83 diff
(90.5 %id)
BI195956 brain, neuroblastoma .e 47 to 796 1 to 743       743/745
(99 %)
15 diff
(98.0 %id)
BI198553 brain, neuroblastoma .k 4 to 776 1 to 787 S107L R108T A109G *110L tiling clone,   787/787
(100 %)
28 diff
(96.5 %id)
BG827250 muscle, rhabdomyosarcoma .a 360 to 1144 1 to 787       787/787
(100 %)
21 diff
(97.4 %id)
BG829339 muscle, rhabdomyosarcoma .a 391 to 1086 1 to 695       695/695
(100 %)
1 diff
(99.9 %id)
BG828065 muscle, rhabdomyosarcoma .a 391 to 1261 1 to 859       859/859
(100 %)
29 diff
(96.7 %id)
BI261498 lymph, lymphoma, cell line .a 358 to 1130 1 to 768   fully sequenced,   768/768
(100 %)
14 diff
(98.2 %id)
BI262117 lymph, lymphoma, cell line .a 1127 to 1704 586 to 4   fully sequenced,   583/586
(99 %)
0 diff
(100 %id)
BI333263 cervical carcinoma cell line, cervix .a 370 to 1041 1 to 672       672/673
(99 %)
4 diff
(99.5 %id)
BI772415 pooled lung and spleen .a 379 to 885 1 to 506       506/506
(100 %)
2 diff
(99.7 %id)
BI906177 leukocyte .k 8 to 743 1 to 737   tiling clone,   737/737
(100 %)
5 diff
(99.4 %id)
BI906736 leukocyte .a 366 to 1180 1 to 820       820/821
(99 %)
16 diff
(98.1 %id)
BI910024 leukocyte .a 352 to 1028 1 to 672       672/672
(100 %)
11 diff
(98.4 %id)
BI908546 leukocyte .a 366 to 992 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
BM008787 adenocarcinoma, Pancreas .a 700 to 1500 1 to 803       803/803
(100 %)
2 diff
(99.8 %id)
BM008896 adenocarcinoma, Pancreas .d 46 to 845 1 to 803   tiling clone,   803/803
(100 %)
10 diff
(98.8 %id)
BM008817 adenocarcinoma, Pancreas .a 700 to 1553 1 to 868       868/868
(100 %)
64 diff
(92.7 %id)
BM020867 astrocytoma grade IV, cell line, brain .a 355 to 1121 1 to 760       760/761
(99 %)
18 diff
(97.7 %id)
BM020205 astrocytoma grade IV, cell line, brain .a 386 to 1102 1 to 714       714/906
(78 %)
14 diff
(98.5 %id)
BM020000 astrocytoma grade IV, cell line, brain .a 355 to 1100 1 to 745       745/745
(100 %)
3 diff
(99.6 %id)
BM908978 astrocytoma grade IV, cell line, brain .a 357 to 862 1 to 507       507/1308
(38 %)
14 diff
(99.0 %id)
BM045024 carcinoma, cell line, Prostate .a 355 to 1132 1 to 778       778/779
(99 %)
7 diff
(99.2 %id)
BM049872 carcinoma, cell line, Prostate .d 4 to 606 1 to 600       600/600
(100 %)
5 diff
(99.2 %id)
BM917173 blood, natural killer cells, cell line .i 1 to 871 3 to 880   tiling clone,   880/1090
(80 %)
17 diff
(98.5 %id)
BM802859 embryonal carcinoma, cell line, testis .d 116 to 896 1 to 782   tiling clone,   782/1129
(69 %)
20 diff
(98.3 %id)
BM903651 ovary (pool of 3) .a 345 to 1101 1 to 763       763/1067
(71 %)
27 diff
(97.5 %id)
BM546889 ovary (pool of 3) .h-u 98 to 995 1 to 898 exact     898/907
(99 %)
6 diff
(99.4 %id)
BQ053473 blood, natural killer cells, cell line .i 1 to 774 3 to 786   tiling clone,   786/1123
(69 %)
23 diff
(98.0 %id)
BQ221377 embryonal carcinoma, cell line, testis .a 336 to 1100 1 to 772       772/858
(89 %)
8 diff
(99.1 %id)
BQ232321 embryonal carcinoma, cell line, testis .h-u 144 to 741 1 to 604       604/871
(69 %)
11 diff
(98.8 %id)
BQ423358 embryonal carcinoma, cell line, testis .d 19 to 552 1 to 534       534/542
(98 %)
21 diff
(96.2 %id)
BU159435 eye, retinoblastoma .c 1 to 872 1 to 886 L228T D229* tiling clone,   886/886
(100 %)
28 diff
(96.9 %id)
BQ959420 epidermoid carcinoma, cell line, lung .a 382 to 1212 1 to 841       841/894
(94 %)
11 diff
(98.8 %id)
BU541962 carcinoma, cell line, Prostate .d 7 to 655 1 to 657 E120*     657/1034
(63 %)
20 diff
(98.1 %id)
BU554026 ovary, teratocarcinoma, cell line .a 374 to 990 45 to 665       621/1047
(59 %)
25 diff
(97.7 %id)
BU931203 ovary, teratocarcinoma, cell line .a 363 to 1100 1 to 742       742/898
(82 %)
15 diff
(98.4 %id)
BU933770 mixed (pool of 40 RNAs) .b 260 to 1014 1 to 773   tiling clone,   773/849
(91 %)
31 diff
(96.4 %id)
BU955866 adenocarcinoma, cell line, breast .a 376 to 948 1 to 573       573/959
(59 %)
13 diff
(98.7 %id)
BU956654 adenocarcinoma, cell line, breast .a 380 to 771 1 to 391       391/967
(40 %)
6 diff
(99.4 %id)
BU956941 adenocarcinoma, cell line, breast .a 380 to 1221 1 to 853       853/881
(96 %)
23 diff
(97.4 %id)
CX872519 embryonic stem .h-u 177 to 591 415 to 1     Submitted on the opposite strand 415/415
(100 %)
1 diff
(99.8 %id)
CV813582 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 380 to 1100 1 to 725   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 725/861
(84 %)
72 diff
(91.7 %id)
DR760949 embryonic stem .a 350 to 569 1 to 220       220/220
(100 %)
2 diff
(99.1 %id)
CD514769 White Matter .e 290 to 1114 1 to 834 exact tiling clone,   834/865
(96 %)
10 diff
(98.9 %id)
DC360142   .f 1 to 514 3 to 517       517/517
(100 %)
4 diff
(99.3 %id)
DA611691   .a 327 to 895 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
TI_57179988   .a 379 to 885 34 to 539       506/539
(93 %)
8 diff
(98.6 %id)
TI_57231693   .k 1 to 743 22 to 764 A2G     743/764
(97 %)
10 diff
(98.7 %id)
TI_57233182   .a 366 to 1180 34 to 853       820/854
(96 %)
21 diff
(97.6 %id)
TI_57236011   .a 353 to 1028 32 to 702       671/702
(95 %)
13 diff
(98.2 %id)
TI_57237217   .a 359 to 992 26 to 658       633/658
(96 %)
7 diff
(99.0 %id)
TI_59386501   .a 700 to 1500 106 to 908       803/803
(100 %)
2 diff
(99.8 %id)
TI_59386533   .a 700 to 1553 60 to 927       868/868
(100 %)
64 diff
(92.7 %id)
TI_59386615   .d 47 to 845 106 to 907       802/802
(100 %)
9 diff
(98.9 %id)
TI_59387827   .a 356 to 1121 98 to 856       759/760
(99 %)
17 diff
(97.8 %id)
TI_59390777   .a 356 to 1100 95 to 838       744/744
(100 %)
2 diff
(99.8 %id)
TI_59390986   .a 387 to 1102 102 to 814       713/905
(78 %)
13 diff
(98.6 %id)
CB107011 Liver .a 482 to 783 1 to 302       302/302
(100 %)
0 diff
(100 %id)
CB108709 Liver .a 329 to 757 1 to 429       429/429
(100 %)
2 diff
(99.6 %id)
CB125686 Liver .a 344 to 878 1 to 535       535/535
(100 %)
2 diff
(99.7 %id)
CB121534 Liver .a 344 to 521 16 to 193       178/178
(100 %)
1 diff
(99.5 %id)
CB137012 Liver .d 1 to 462 1 to 462   tiling clone,   462/462
(100 %)
0 diff
(100 %id)
CB131086 Liver .a 343 to 509 1 to 167       167/167
(100 %)
2 diff
(98.9 %id)
CB140359 Liver .a 336 to 707 1 to 372       372/372
(100 %)
3 diff
(99.2 %id)
CB149057 Liver .a 343 to 739 1 to 397       397/397
(100 %)
5 diff
(98.8 %id)
NM_007243.1   .a 336 to 1753 1 to 1418   RefSeq, AAA   1418/1418
(100 %)
0 diff
(100 %id)
DA844488 placenta .a 345 to 900 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BM846646 myeloma .e 1 to 602 3 to 604       604/604
(100 %)
2 diff
(99.7 %id)
BM847576 myeloma .e 1 to 622 3 to 624   tiling clone,   624/624
(100 %)
3 diff
(99.6 %id)
BM789752 Ascites, stomach .g 1 to 483 1 to 483   tiling clone,   483/483
(100 %)
1 diff
(99.8 %id)
TI_1948208725   .a 353 to 862 136 to 646   fully sequenced,   511/646
(79 %)
9 diff
(98.7 %id)
TI_1948208726   .a 830 to 1148 435 to 116   fully sequenced,   320/435
(73 %)
0 diff
(100 %id)
TI_1948208895   .a 353 to 759 123 to 532   fully sequenced,   410/532
(77 %)
7 diff
(98.7 %id)
TI_1948208896   .a 729 to 1148 538 to 119   fully sequenced,   420/538
(78 %)
3 diff
(99.5 %id)
TI_1948209063   .a 353 to 787 128 to 563   fully sequenced,   436/563
(77 %)
6 diff
(99.0 %id)
TI_1948209064   .a 757 to 1148 511 to 120   fully sequenced,   392/511
(76 %)
1 diff
(99.9 %id)
TI_1948209230   .b 131 to 793 786 to 117   tiling clone,   668/1266
(52 %)
50 diff
(96.1 %id)
DN996598 breast cancer, Mammary gland (cancer tissue) .a 348 to 905 8 to 566       559/566
(98 %)
7 diff
(98.8 %id)
BM666750 eye, human retina .h-u 337 to 997 680 to 19   AAA   662/662
(100 %)
2 diff
(99.7 %id)
BM697698 eye, fetal eyes .b 239 to 759 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BU735861 eye, fetal eyes .b 1162 to 1396 254 to 20   tiling clone, AAA   235/235
(100 %)
1 diff
(99.6 %id)
BQ188942 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h-u 697 to 997 1 to 301   AAA   301/301
(100 %)
0 diff
(100 %id)
BM728816 eye, fetal eye .h-u 311 to 987 1 to 677       677/677
(100 %)
0 diff
(100 %id)
BQ447134 Knee, Osteoarthritic Cartilage .h-u 465 to 997 551 to 19   AAA   533/533
(100 %)
12 diff
(97.8 %id)
BQ448417 Knee, Osteoarthritic Cartilage .h-u 369 to 999 647 to 17   AAA   631/631
(100 %)
0 diff
(100 %id)
TI_153963453   .h-u 118 to 976 83 to 929 E5D P6A L7S A8W L9P ...     847/989
(85 %)
24 diff
(97.6 %id)
TI_151733749   .h-u 697 to 997 378 to 78   AAA   301/904
(33 %)
0 diff
(100 %id)
TI_151759765   .h-u 311 to 999 780 to 92   AAA   689/945
(72 %)
1 diff
(99.9 %id)
DB250483 uterus .l-u 2 to 585 2 to 585 exact tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
AA405544   .a 391 to 1261 1 to 859     Suspected internal deletion, this clone was ignored 859/859
(100 %)
29 diff
(96.7 %id)
AA405598   .a 358 to 1130 1 to 768     Suspected internal deletion, this clone was ignored 768/768
(100 %)
14 diff
(98.2 %id)
AW450747   .a 358 to 1130 1 to 768   AAA Suspected internal deletion, this clone was ignored 768/768
(100 %)
14 diff
(98.2 %id)
BI262117 lymph, lymphoma, cell line .a 1127 to 1704 586 to 4   fully sequenced,   583/586
(99 %)
0 diff
(100 %id)
BI262117 lymph, lymphoma, cell line .a 1127 to 1704 586 to 4   fully sequenced,   583/586
(99 %)
0 diff
(100 %id)
BI333263 cervical carcinoma cell line, cervix .a 370 to 1041 1 to 672       672/673
(99 %)
4 diff
(99.5 %id)
BI333263 cervical carcinoma cell line, cervix .a 370 to 1041 1 to 672       672/673
(99 %)
4 diff
(99.5 %id)
BI772415 pooled lung and spleen .a 379 to 885 1 to 506       506/506
(100 %)
2 diff
(99.7 %id)
BI906177 leukocyte .k 8 to 743 1 to 737   tiling clone,   737/737
(100 %)
5 diff
(99.4 %id)
BI906736 leukocyte .a 366 to 1180 1 to 820       820/821
(99 %)
16 diff
(98.1 %id)
BI910024 leukocyte .a 352 to 1028 1 to 672       672/672
(100 %)
11 diff
(98.4 %id)
BI908546 leukocyte .a 366 to 992 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
BM008787 adenocarcinoma, Pancreas .a 700 to 1500 1 to 803       803/803
(100 %)
2 diff
(99.8 %id)
BM008787 adenocarcinoma, Pancreas .a 700 to 1500 1 to 803       803/803
(100 %)
2 diff
(99.8 %id)
BM008896 adenocarcinoma, Pancreas .d 46 to 845 1 to 803   tiling clone,   803/803
(100 %)
10 diff
(98.8 %id)
BM008896 adenocarcinoma, Pancreas .d 46 to 845 1 to 803   tiling clone,   803/803
(100 %)
10 diff
(98.8 %id)
BM008817 adenocarcinoma, Pancreas .a 700 to 1553 1 to 868       868/868
(100 %)
64 diff
(92.7 %id)
BM008817 adenocarcinoma, Pancreas .a 700 to 1553 1 to 868       868/868
(100 %)
64 diff
(92.7 %id)
BM020867 astrocytoma grade IV, cell line, brain .a 355 to 1121 1 to 760       760/761
(99 %)
18 diff
(97.7 %id)
BM020867 astrocytoma grade IV, cell line, brain .a 355 to 1121 1 to 760       760/761
(99 %)
18 diff
(97.7 %id)
BM020205 astrocytoma grade IV, cell line, brain .a 386 to 1102 1 to 714       714/906
(78 %)
14 diff
(98.5 %id)
BM020205 astrocytoma grade IV, cell line, brain .a 386 to 1102 1 to 714       714/906
(78 %)
14 diff
(98.5 %id)
BM020000 astrocytoma grade IV, cell line, brain .a 355 to 1100 1 to 745       745/745
(100 %)
3 diff
(99.6 %id)
BM020000 astrocytoma grade IV, cell line, brain .a 355 to 1100 1 to 745       745/745
(100 %)
3 diff
(99.6 %id)
BM908978 astrocytoma grade IV, cell line, brain .a 357 to 862 1 to 507       507/1308
(38 %)
14 diff
(99.0 %id)
BM908978 astrocytoma grade IV, cell line, brain .a 357 to 862 1 to 507       507/1308
(38 %)
14 diff
(99.0 %id)
BM045024 carcinoma, cell line, Prostate .a 355 to 1132 1 to 778       778/779
(99 %)
7 diff
(99.2 %id)
BM045024 carcinoma, cell line, Prostate .a 355 to 1132 1 to 778       778/779
(99 %)
7 diff
(99.2 %id)
BM049872 carcinoma, cell line, Prostate .d 4 to 606 1 to 600       600/600
(100 %)
5 diff
(99.2 %id)
BM049872 carcinoma, cell line, Prostate .d 4 to 606 1 to 600       600/600
(100 %)
5 diff
(99.2 %id)
BM917173 blood, natural killer cells, cell line .i 1 to 871 3 to 880   tiling clone,   880/1090
(80 %)
17 diff
(98.5 %id)
BM917173 blood, natural killer cells, cell line .i 1 to 871 3 to 880   tiling clone,   880/1090
(80 %)
17 diff
(98.5 %id)
BM802859 embryonal carcinoma, cell line, testis .d 116 to 896 1 to 782   tiling clone,   782/1129
(69 %)
20 diff
(98.3 %id)
BM802859 embryonal carcinoma, cell line, testis .d 116 to 896 1 to 782   tiling clone,   782/1129
(69 %)
20 diff
(98.3 %id)
BM903651 ovary (pool of 3) .a 345 to 1101 1 to 763       763/1067
(71 %)
27 diff
(97.5 %id)
BM546889 ovary (pool of 3) .h-u 98 to 995 1 to 898 exact     898/907
(99 %)
6 diff
(99.4 %id)
BQ053473 blood, natural killer cells, cell line .i 1 to 774 3 to 786   tiling clone,   786/1123
(69 %)
23 diff
(98.0 %id)
BQ053473 blood, natural killer cells, cell line .i 1 to 774 3 to 786   tiling clone,   786/1123
(69 %)
23 diff
(98.0 %id)
BQ221377 embryonal carcinoma, cell line, testis .a 336 to 1100 1 to 772       772/858
(89 %)
8 diff
(99.1 %id)
BQ221377 embryonal carcinoma, cell line, testis .a 336 to 1100 1 to 772       772/858
(89 %)
8 diff
(99.1 %id)
BQ232321 embryonal carcinoma, cell line, testis .h-u 144 to 741 1 to 604       604/871
(69 %)
11 diff
(98.8 %id)
BQ232321 embryonal carcinoma, cell line, testis .h-u 144 to 741 1 to 604       604/871
(69 %)
11 diff
(98.8 %id)
BQ423358 embryonal carcinoma, cell line, testis .d 19 to 552 1 to 534       534/542
(98 %)
21 diff
(96.2 %id)
BQ423358 embryonal carcinoma, cell line, testis .d 19 to 552 1 to 534       534/542
(98 %)
21 diff
(96.2 %id)
BU159435 eye, retinoblastoma .c 1 to 872 1 to 886 L228T D229* tiling clone,   886/886
(100 %)
28 diff
(96.9 %id)
BU159435 eye, retinoblastoma .c 1 to 872 1 to 886 L228T D229* tiling clone,   886/886
(100 %)
28 diff
(96.9 %id)
BQ959420 epidermoid carcinoma, cell line, lung .a 382 to 1212 1 to 841       841/894
(94 %)
11 diff
(98.8 %id)
BQ959420 epidermoid carcinoma, cell line, lung .a 382 to 1212 1 to 841       841/894
(94 %)
11 diff
(98.8 %id)
BU541962 carcinoma, cell line, Prostate .d 7 to 655 1 to 657 E120*     657/1034
(63 %)
20 diff
(98.1 %id)
BU541962 carcinoma, cell line, Prostate .d 7 to 655 1 to 657 E120*     657/1034
(63 %)
20 diff
(98.1 %id)
BU554026 ovary, teratocarcinoma, cell line .a 374 to 990 45 to 665       621/1047
(59 %)
25 diff
(97.7 %id)
BU554026 ovary, teratocarcinoma, cell line .a 374 to 990 45 to 665       621/1047
(59 %)
25 diff
(97.7 %id)
BU931203 ovary, teratocarcinoma, cell line .a 363 to 1100 1 to 742       742/898
(82 %)
15 diff
(98.4 %id)
BU931203 ovary, teratocarcinoma, cell line .a 363 to 1100 1 to 742       742/898
(82 %)
15 diff
(98.4 %id)
BU933770 mixed (pool of 40 RNAs) .b 260 to 1014 1 to 773   tiling clone,   773/849
(91 %)
31 diff
(96.4 %id)
BU955866 adenocarcinoma, cell line, breast .a 376 to 948 1 to 573       573/959
(59 %)
13 diff
(98.7 %id)
BU955866 adenocarcinoma, cell line, breast .a 376 to 948 1 to 573       573/959
(59 %)
13 diff
(98.7 %id)
BU956654 adenocarcinoma, cell line, breast .a 380 to 771 1 to 391       391/967
(40 %)
6 diff
(99.4 %id)
BU956654 adenocarcinoma, cell line, breast .a 380 to 771 1 to 391       391/967
(40 %)
6 diff
(99.4 %id)
BU956941 adenocarcinoma, cell line, breast .a 380 to 1221 1 to 853       853/881
(96 %)
23 diff
(97.4 %id)
BU956941 adenocarcinoma, cell line, breast .a 380 to 1221 1 to 853       853/881
(96 %)
23 diff
(97.4 %id)
CX872519 embryonic stem .h-u 177 to 591 415 to 1     Submitted on the opposite strand 415/415
(100 %)
1 diff
(99.8 %id)
CV813582 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 380 to 1100 1 to 725   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 725/861
(84 %)
72 diff
(91.7 %id)
CV813582 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 380 to 1100 1 to 725   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 725/861
(84 %)
72 diff
(91.7 %id)
DR760949 embryonic stem .a 350 to 569 1 to 220       220/220
(100 %)
2 diff
(99.1 %id)
CD514769 White Matter .e 290 to 1114 1 to 834 exact tiling clone,   834/865
(96 %)
10 diff
(98.9 %id)
DC360142   .f 1 to 514 3 to 517       517/517
(100 %)
4 diff
(99.3 %id)
DA611691   .a 327 to 895 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
TI_57179988   .a 379 to 885 34 to 539       506/539
(93 %)
8 diff
(98.6 %id)
TI_57231693   .k 1 to 743 22 to 764 A2G     743/764
(97 %)
10 diff
(98.7 %id)
TI_57233182   .a 366 to 1180 34 to 853       820/854
(96 %)
21 diff
(97.6 %id)
TI_57236011   .a 353 to 1028 32 to 702       671/702
(95 %)
13 diff
(98.2 %id)
TI_57237217   .a 359 to 992 26 to 658       633/658
(96 %)
7 diff
(99.0 %id)
TI_59386501   .a 700 to 1500 106 to 908       803/803
(100 %)
2 diff
(99.8 %id)
TI_59386533   .a 700 to 1553 60 to 927       868/868
(100 %)
64 diff
(92.7 %id)
TI_59386615   .d 47 to 845 106 to 907       802/802
(100 %)
9 diff
(98.9 %id)
TI_59387827   .a 356 to 1121 98 to 856       759/760
(99 %)
17 diff
(97.8 %id)
TI_59390777   .a 356 to 1100 95 to 838       744/744
(100 %)
2 diff
(99.8 %id)
TI_59390986   .a 387 to 1102 102 to 814       713/905
(78 %)
13 diff
(98.6 %id)
CB107011 Liver .a 482 to 783 1 to 302       302/302
(100 %)
0 diff
(100 %id)
CB108709 Liver .a 329 to 757 1 to 429       429/429
(100 %)
2 diff
(99.6 %id)
CB125686 Liver .a 344 to 878 1 to 535       535/535
(100 %)
2 diff
(99.7 %id)
CB121534 Liver .a 344 to 521 16 to 193       178/178
(100 %)
1 diff
(99.5 %id)
CB137012 Liver .d 1 to 462 1 to 462   tiling clone,   462/462
(100 %)
0 diff
(100 %id)
CB131086 Liver .a 343 to 509 1 to 167       167/167
(100 %)
2 diff
(98.9 %id)
CB140359 Liver .a 336 to 707 1 to 372       372/372
(100 %)
3 diff
(99.2 %id)
CB149057 Liver .a 343 to 739 1 to 397       397/397
(100 %)
5 diff
(98.8 %id)
NM_007243.1   .a 336 to 1753 1 to 1418   RefSeq, AAA   1418/1418
(100 %)
0 diff
(100 %id)
DA844488 placenta .a 345 to 900 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BM846646 myeloma .e 1 to 602 3 to 604       604/604
(100 %)
2 diff
(99.7 %id)
BM847576 myeloma .e 1 to 622 3 to 624   tiling clone,   624/624
(100 %)
3 diff
(99.6 %id)
BM789752 Ascites, stomach .g 1 to 483 1 to 483   tiling clone,   483/483
(100 %)
1 diff
(99.8 %id)
BM789752 Ascites, stomach .g 1 to 483 1 to 483   tiling clone,   483/483
(100 %)
1 diff
(99.8 %id)
TI_1948208725   .a 353 to 862 136 to 646   fully sequenced,   511/646
(79 %)
9 diff
(98.7 %id)
TI_1948208726   .a 830 to 1148 435 to 116   fully sequenced,   320/435
(73 %)
0 diff
(100 %id)
TI_1948208895   .a 353 to 759 123 to 532   fully sequenced,   410/532
(77 %)
7 diff
(98.7 %id)
TI_1948208896   .a 729 to 1148 538 to 119   fully sequenced,   420/538
(78 %)
3 diff
(99.5 %id)
TI_1948209063   .a 353 to 787 128 to 563   fully sequenced,   436/563
(77 %)
6 diff
(99.0 %id)
TI_1948209064   .a 757 to 1148 511 to 120   fully sequenced,   392/511
(76 %)
1 diff
(99.9 %id)
TI_1948209230   .b 131 to 793 786 to 117   tiling clone,   668/1266
(52 %)
50 diff
(96.1 %id)
DN996598 breast cancer, Mammary gland (cancer tissue) .a 348 to 905 8 to 566       559/566
(98 %)
7 diff
(98.8 %id)
DN996598 breast cancer, Mammary gland (cancer tissue) .a 348 to 905 8 to 566       559/566
(98 %)
7 diff
(98.8 %id)
BM666750 eye, human retina .h-u 337 to 997 680 to 19   AAA   662/662
(100 %)
2 diff
(99.7 %id)
BM666750 eye, human retina .h-u 337 to 997 680 to 19   AAA   662/662
(100 %)
2 diff
(99.7 %id)
BM697698 eye, fetal eyes .b 239 to 759 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BM697698 eye, fetal eyes .b 239 to 759 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BU735861 eye, fetal eyes .b 1162 to 1396 254 to 20   tiling clone, AAA   235/235
(100 %)
1 diff
(99.6 %id)
BU735861 eye, fetal eyes .b 1162 to 1396 254 to 20   tiling clone, AAA   235/235
(100 %)
1 diff
(99.6 %id)
BQ188942 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h-u 697 to 997 1 to 301   AAA   301/301
(100 %)
0 diff
(100 %id)
BQ188942 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h-u 697 to 997 1 to 301   AAA   301/301
(100 %)
0 diff
(100 %id)
BM728816 eye, fetal eye .h-u 311 to 987 1 to 677       677/677
(100 %)
0 diff
(100 %id)
BM728816 eye, fetal eye .h-u 311 to 987 1 to 677       677/677
(100 %)
0 diff
(100 %id)
BQ447134 Knee, Osteoarthritic Cartilage .h-u 465 to 997 551 to 19   AAA   533/533
(100 %)
12 diff
(97.8 %id)
BQ447134 Knee, Osteoarthritic Cartilage .h-u 465 to 997 551 to 19   AAA   533/533
(100 %)
12 diff
(97.8 %id)
BQ448417 Knee, Osteoarthritic Cartilage .h-u 369 to 999 647 to 17   AAA   631/631
(100 %)
0 diff
(100 %id)
BQ448417 Knee, Osteoarthritic Cartilage .h-u 369 to 999 647 to 17   AAA   631/631
(100 %)
0 diff
(100 %id)
TI_153963453   .h-u 118 to 976 83 to 929 E5D P6A L7S A8W L9P ...     847/989
(85 %)
24 diff
(97.6 %id)
TI_151733749   .h-u 697 to 997 378 to 78   AAA   301/904
(33 %)
0 diff
(100 %id)
TI_151759765   .h-u 311 to 999 780 to 92   AAA   689/945
(72 %)
1 diff
(99.9 %id)
DB250483 uterus .l-u 2 to 585 2 to 585 exact tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C